C3 glomerulopathy and eculizumab: a report on four paediatric cases.
Background: Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe glomerular disease. Diagnosis and Treatment: Patients 1, 2 and 3 were diagnosed with nephritic syndrome with alternative complement pathway activation (low C3, C3Nef-positive) and C3G at the age of 9, 13 and 12 ye...
| Publicado en: | Pediatric Nephrology Vol. 32; no. 6; pp. 1023 - 1029 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | case study research tables/charts Journal Article |
| Publicado: |
Springer Nature
Jun2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |